- Home
- WSBC vs DNLI Comparison
WSBC vs DNLI Comparison
Compare WSBC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- DNLI
- Stock Information
- Founded
- WSBC 1870
- DNLI 2013
- Country
- WSBC United States
- DNLI United States
- Employees
- WSBC N/A
- DNLI N/A
- Industry
- WSBC Major Banks
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSBC Finance
- DNLI Health Care
- Exchange
- WSBC Nasdaq
- DNLI Nasdaq
- Market Cap
- WSBC 2.9B
- DNLI 2.5B
- IPO Year
- WSBC N/A
- DNLI 2017
- Fundamental
- Price
- WSBC $30.39
- DNLI $17.25
- Analyst Decision
- WSBC Buy
- DNLI Strong Buy
- Analyst Count
- WSBC 5
- DNLI 13
- Target Price
- WSBC $39.60
- DNLI $32.64
- AVG Volume (30 Days)
- WSBC 507.2K
- DNLI 1.4M
- Earning Date
- WSBC 10-22-2025
- DNLI 11-06-2025
- Dividend Yield
- WSBC 4.86%
- DNLI N/A
- EPS Growth
- WSBC N/A
- DNLI N/A
- EPS
- WSBC 2.04
- DNLI N/A
- Revenue
- WSBC $804,347,000.00
- DNLI N/A
- Revenue This Year
- WSBC $42.29
- DNLI N/A
- Revenue Next Year
- WSBC $20.56
- DNLI $94,232.03
- P/E Ratio
- WSBC $14.90
- DNLI N/A
- Revenue Growth
- WSBC 41.87
- DNLI N/A
- 52 Week Low
- WSBC $26.42
- DNLI $10.57
- 52 Week High
- WSBC $37.36
- DNLI $26.18
- Technical
- Relative Strength Index (RSI)
- WSBC 44.97
- DNLI 57.29
- Support Level
- WSBC $29.75
- DNLI $16.66
- Resistance Level
- WSBC $31.92
- DNLI $18.21
- Average True Range (ATR)
- WSBC 0.70
- DNLI 1.06
- MACD
- WSBC 0.01
- DNLI 0.12
- Stochastic Oscillator
- WSBC 33.56
- DNLI 66.46
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.